Considering the bioavailability concerns of MPO’s parent drug, apocynin, MPO likely presents a similar challenge for drug distribution to the hippocampus, the brain region that is markedly affected in epilepsy [1,25,26]. This evidence concerns the gene MPO and epilepsy.